Can corticosteroid injections cause alopecia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 31, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Corticosteroid Injections and Alopecia

Yes, corticosteroid injections can both treat and cause alopecia, depending on the context and application. 1, 2

Corticosteroid Injections for Treating Alopecia Areata

  • Intralesional corticosteroid injections are the first-line treatment for limited patchy hair loss in alopecia areata 2, 3
  • Triamcinolone acetonide (5-10 mg/mL) is commonly used, with success rates of up to 62% reported with monthly injections 4, 3
  • Injections of 0.05-0.1 mL per site can produce a tuft of hair growth about 0.5 cm in diameter 2, 4
  • The effect typically lasts about 9 months, with tufts of hair growing in 33 of 34 sites injected with triamcinolone hexacetonide and in 16 of 25 sites injected with triamcinolone acetonide 2, 4
  • Methylprednisolone acetate is FDA-approved for intralesional use in alopecia areata 1

Side Effects of Corticosteroid Injections Including Alopecia

  • Skin atrophy at the injection site is a consistent side effect of intralesional corticosteroids, particularly with triamcinolone 4, 3
  • Localized alopecia can occur at injection sites due to skin atrophy and disruption of hair follicles 4
  • Other local adverse effects may include pigmentary changes, telangiectasias, and hypertrichosis 5
  • Dermoscopy can identify adverse effects earlier than clinical examination 6

Best Candidates for Intralesional Corticosteroid Treatment

  • Most suitable for patients with fewer than five patches of hair loss, each less than 3 cm in diameter 4, 3
  • Better response rates in localized alopecia compared to extensive hair loss 4, 7
  • Less effective in alopecia totalis or universalis patterns 8
  • Multiple injections may be given, with the main limitation being patient discomfort 2

Alternative Approaches for Extensive Alopecia

  • Contact immunotherapy (diphenylcyclopropenone) is recommended as first-line treatment for extensive patchy hair loss 3
  • Systemic corticosteroids may be considered for severe cases but are not routinely recommended due to potential serious side effects 3, 9, 10
  • No treatment is a legitimate option for many patients, especially those with limited disease of short duration (<1 year), as spontaneous remission occurs in up to 80% of such cases 2, 3

Clinical Pearls and Pitfalls

  • Intralesional corticosteroids should be injected just beneath the dermis in the upper subcutis for optimal effect 2, 4
  • Needleless devices (e.g., Dermajet) can be used as an alternative administration method 2, 4
  • Folliculitis is a common side effect of treatment with potent topical steroids 2
  • Relapse following treatment discontinuation is common, particularly with systemic corticosteroid therapy 9, 10
  • Dermoscopy can be used to monitor treatment response, with new vellus hair growth often visible at 4 weeks 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Alopecia Areata

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Triamcinolone Injection in the Neck: Appropriateness and Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tricortone 0.02% Ointment Uses for Inflammatory Skin Conditions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Sequential high- and low-dose systemic corticosteroid therapy for severe childhood alopecia areata.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2017

Research

Severe alopecia areata treated with systemic corticosteroids.

International journal of dermatology, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.